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a  b  s  t  r  a  c  t
Transient  Receptor  Potential  Melastatin  3  (TRPM3)  is a widely  expressed  calcium-permeable  non-
selective  cation  channel  that  is  stimulated  by  high  concentrations  of  nifedipine  or by  physiological
steroids  that  include  pregnenolone  sulphate.  Here  we sought  to identify  steroids  that  inhibit  TRPM3.
Channel  activity  was  studied  using  calcium-measurement  and  patch-clamp  techniques.  Progesterone
(0.01–10  M)  suppressed  TRPM3  activity  evoked  by pregnenolone  sulphate.  Progesterone  metabolites
and  17-oestradiol  were  also  inhibitory  but  the effects  were  relatively  small.  Dihydrotestosterone  was
an inhibitor  at  concentrations  higher  than  1  M.  Corticosteroids  lacked  effect.  Overlay  assays  indi-
cated  that  pregnenolone  sulphate,  progesterone  and  dihydrotestosterone  bound  to TRPM3.  In contrast
to  dihydrotestosterone,  progesterone  inhibited  nifedipine-evoked  TRPM3  activity  or  activity  in  the
absence  of  an exogenous  activator,  suggesting  a pregnenolone  sulphate-independent  mechanism  of
action.  Dihydrotestosterone,  like  a non-steroid  look-alike  compound,  acted  as a  competitive  antago-regnenolone
rogesterone
nist at the pregnenolone  sulphate  binding  site.  Progesterone  inhibited  endogenous  TRPM3  in vascular
smooth  muscle  cells.  Relevance  of TRPM3  or  the  progesterone  effect  to ovarian  cells, which  have
been  suggested  to  express  TRPM3,  was  not  identiﬁed.  The  data  further  deﬁne  a chemical  framework
for  competition  with  pregnenolone  sulphate  at TRPM3  and  expand  knowledge  of  steroid  interactions
with  TRPM3,  suggesting  direct  steroid  binding  and  pregnenolone  sulphate-independent  inhibition  by
progesterone.
wn CoCro
. IntroductionThe Transient Receptor Potential Melastatin 3 (TRPM3) cationic
hannel is expressed quite widely in mammalian cells such as
Abbreviations: Aldo, aldosterone; Cort, cortisol; DhT, dihydrotestosterone;
EK 293 cells, human embryonic kidney cells; La3+, lanthanum; Mfp, mifepri-
tone; Nif, nifedipine; PregS, pregnenolone sulphate; Prog, progesterone; 5,
regnanolone; 5, allopregnanolone; 17-OH, 17-hydroxyprogesterone; 21-OH,
1-hydroxyprogesterone; Oest, 17-oestradiol; TG, thapsigargin; TRP, transient
eceptor potential; VSMC, vascular smooth muscle cell; 2-CMNPBC, 2-chloro-4-
methylsulphonyl)-N-[4-(1 pyrrolidinyl)phenyl]benzenecarboxamide.
∗ Corresponding author at: Institute of Membrane & Systems Biology, Garstang
uilding, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.
el.: +44 0113 343 4323; fax: +44 0113 343 4228.
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pancreatic -cells, oligodendrocytes, vascular smooth muscle
cells, and sensory neurones [1–4]. It has been found to mod-
ulate secretion of factors including insulin and interleukin-6,
promote vascular contraction, enable heat-sensing, and confer
zinc inﬂux [3–5] but there remains relatively little knowledge
of its physiological signiﬁcance and regulation. There has been
interest in the potential for chemical modulation because many
other types of TRP channel serve chemical-sensing functions [6].
TRPM3 has been found to be stimulated, inhibited or unaffected
by sphingosine [1,3,7] and stimulated by pregnenolone sulphate
[1].  The pregnenolone sulphate effect is most striking, reﬂect-
ing non-genomic steroid-sensing capability of TRPM3 channels
Open access under CC BY license.[1]. The data are consistent with the existence of an extra-
cellular stereo-speciﬁc binding site, on or near TRPM3, which
accepts a limited number of steroids including pregnenolone, preg-
nenolone sulphate and epipregnanolone sulphate [8].  Many other
.
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teroids, including sex steroids, are not stimulators of TRPM3
1]. Low-level constitutive activity of TRPM3 has been described
or over-expressed and endogenous channels [3,9]. An identiﬁed
ndogenous inhibitor is cholesterol, which is the precursor of
teroid hormones [3]. Non-physiological chemical modulators of
RPM3 include the dihydropyridine nifedipine which stimulates
RPM3 [1,10],  and 2-aminoethoxydiphenyl borate, mefenamic acid
nd the thiazolidinediones rosiglitazone, troglitazone and pioglita-
one which inhibit TRPM3 [10–12].  The aims of this study were
o further characterise the steroid sensitivity of TRPM3 and deter-
ine if any endogenous steroid hormones are inhibitors of the
hannel.
. Methods
.1. HEK 293 cell culture
The tetracycline-regulated expression of human TRPM3 in HEK
93 cells has been previously described [8].  Cells not induced
ith tetracycline (Tet− cells) were controls. The tetracycline-
egulated expression of human TRPM2 in HEK 293 has also been
escribed [13]. Cells were maintained in Dulbecco’s Modiﬁed
agle’s Medium-F12 + GLUTAMAX (Cat # 31331, Gibco, Paisley,
K) supplemented with 10% foetal calf serum, 100 units/ml peni-
illin/streptomycin (Sigma) and selection antibiotics (10 g/ml
lasticidin and 400 g/ml zeocin; Invitrogen) at 37 ◦C in a 5% CO2
ncubator.
.2. Vascular smooth muscle cells
Freshly discarded human saphenous vein segments were
btained anonymously and with informed consent from patients
ndergoing open heart surgery in the General Inﬁrmary at Leeds.
pproval was granted by the Leeds Teaching Hospitals Local
esearch Ethics Committee. Proliferating vascular smooth mus-
le cells (VSMCs) were prepared using an explant technique and
rown in Dulbecco’s Modiﬁed Eagle’s Medium + GLUTAMAX (Cat
 31966, GIBCO). The medium was supplemented with 10% foetal
alf serum, 100 U/ml penicillin/streptomycin (Sigma) at 37 ◦C in a
% CO2 incubator. Experiments were performed on cells passaged
–5 times.
.3. Ovarian granulosa cells
Bovine granulosa cells were harvested from abattoir-derived
ovine ovaries from at least 6 heifers at random stages of the
estrous cycle on 5 separate occasions. Reproductive tracts were
ecovered within 3 h of slaughter and transported to the labora-
ory at ambient temperature in an insulated box. The ovaries were
emoved from the reproductive tract and washed in phosphate-
uffered saline (PBS, pH 7.4), containing 100 IU/ml penicillin G,
00 g/ml streptomycin sulphate and 250 ng/ml amphotericin B,
hich had been pre-warmed to 39 ◦C. Granulosa cells were isolated
sing methodology adapted from Gutierrez et al. [14]. During isola-
ion the ovaries were retained in pre-warmed bicarbonate-buffered
cCoy’s 5a medium supplemented with: 20 mM HEPES, 0.1%
w/v) fatty acid-free bovine serum albumen, 100 IU/ml penicillin
, 100 g/ml streptomycin sulphate, 2.5 g/ml bovine transferrin,
 ng/ml sodium selenite, and 3 mM l-glutamine. 15–20 follicles
f 7–20 mm diameter were collected, washed in culture medium,
he follicular ﬂuid aspirated using a 1 ml  syringe ﬁtted with a 23-
auge needle and each follicle was bisected into a small Petri dish
ontaining 3 ml  of cell culture media. The granulosa cells were
emoved by gently scraping the follicle wall with a sterile inoc-
lation loop and cells were pooled across all follicles. The cell
uspension was transferred to a 15-ml centrifuge tube and washedum 51 (2012) 1– 11
twice in a total volume of 12 ml  of medium followed by cen-
trifugation at 1200 rpm for 10 min  at room temperature. The cell
pellet was re-suspended in 5 ml  of culture medium supplemented
with 10 ng/ml of bovine insulin, 1 ng/ml of the synthetic insulin
like growth factor I (IGF-I) analogue LR3-IGF-I, and ovine follicle
stimulating hormone (1 mU/ml) and ovine luteinizing hormone
(0.5 mU/ml). At these concentrations, the gonadotrophins induce
granulosa cell luteinization and high levels of progesterone produc-
tion in vitro. The granulosa cell culture media was  pre-equilibrated
to 39 ◦C and 5% CO2 in air in a humidiﬁed incubator. Whole-cell
patch-clamp was performed on the day of isolation over a period
of 4–5 h.
2.4. Ca2+ measurement
For intracellular Ca2+ measurement, cells were plated at a con-
ﬂuence of 80–90% in clear-bottom poly-d-lysine coated 96-well
plates (Corning, NY, USA) for 24 h prior to experiments. Immedi-
ately prior to recordings, cells were incubated for 1 h at 37 ◦C in
standard bath solution (SBS) containing 2 M fura-2 acetoxymethyl
ester (and 0.01% pluronic acid) and then washed with SBS once
before adding the recording buffer (SBS with appropriate solvent).
All experiments were performed at 23 ± 2 ◦C. SBS contained (mM):
NaCl 130, KCl 5, MgCl2 1.2, CaCl2 1.5, glucose 8, d-mannitol 11,
and HEPES 10 in deionised water; pH was titrated to 7.4 using
4 M NaOH. Measurements were made on a 96-well ﬂuorescence
plate reader (FlexStation II384, Molecular Devices, Sunnyvale, CA,
USA). Fura-2 was  excited by light of 340 and 380 nm and emitted
light was collected at 510 nm.  Wells of the 96-well plate were stud-
ied in a column format and loaded alternately for test and control
conditions. Change () in intracellular calcium (Cai2+) concentra-
tion is indicated as the ratio of fura-2 ﬂuorescence (F) emission
intensities for 340 nm and 380 nm (F ratio). All experiments were
performed at room temperature (23 ± 2 ◦C), unless indicated oth-
erwise.
2.5. Electrophysiology
Borosilicate glass capillaries with an outside diameter of 1 mm
and an inside diameter of 0.58 mm (Harvard Apparatus, Hollis-
ton, MA,  USA) were used as the basis for patch pipettes. Pipette
resistance after ﬁre-polishing and when ﬁlled with ionic solu-
tions were 3–5 M.  The pipettes were mounted on a CV203BU
head-stage (Molecular Devices, Sunnyvale, CA, USA) connected to
a 3-way coarse manipulator and a micro-manipulator (Newport
300P, Newport Corporation, Irvine, CA, USA). Electrodes comprised
silver wires coated with chloride ions. Electrical signals were ampli-
ﬁed and recorded using an Axopatch 200B ampliﬁer and pCLAMP
8 software (Molecular Devices, Sunnyvale, CA, USA). Data were ﬁl-
tered at 1 kHz and sampled digitally at 2 kHz via a Digidata 1322A
analogue to digital converter (Molecular Devices, Sunnyvale, CA,
USA). Recordings were made at least 5 min  after break-through
to the whole-cell conﬁguration. Series resistance was <10 M.
The voltage-ramp protocol was a step from a holding poten-
tial of 0 mV  to −100 mV,  followed by a 0.1-s ramp to +100 mV,
before returning to 0 mV  (repeated every 10 s). The extracellu-
lar solution contained (mM):  NaCl 130, KCl 5, CsCl 10, MgCl2 1.2,
CaCl2 1.5, glucose 8 and HEPES 10, with pH titrated to 7.4 using
4 M NaOH. The osmolality of this solution was 295 mOsm/L. The
patch pipette solution contained (mM):  CsAspartate 80, CsCl 45,
HEPES 10, BAPTA sodium 10, Na2ATP 4; osmolality was  adjusted
to 290 mOsm/L using d-mannitol and the pH was titrated to
7.2 using 4 M CsOH. The pipette solution was ﬁltered using a
0.2-m membrane ﬁlter (Minisart Sartorius Stedim biotech, Goet-
tingen, Germany), divided into aliquots of approximately 50 L and
stored at −20 ◦C. All experiments were at 23 ± 2 ◦C. For K+-current
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ecording, the patch pipette solution contained (mM):  NaCl 5, KCl
30, MgCl2 2, EGTA 5, HEPES 10, Na2ATP 3 (pH 7.4 using KOH).
nalysis was performed off-line using Clampﬁt 8.2 (Molecular
evices, Sunnyvale, CA, USA) and Origin 7.5 software (Origin-
ab, Northampton, MA,  USA). Background-subtracted TRPM3 I–Vs
ere smoothed using the adjacent-averaging algorithm in Origin
.5.
.6. Steroid overlay assay
The assay was performed largely as described previously [15].
rieﬂy, HEK 293 cells transfected with plasmids encoding TRPM3-
FP or GFP were harvested in PBS. Cell pellets were homogenized
sing 1 ml  of 50 mM Tris (pH 7.4) containing 0.2% CHAPS and
rotease inhibitor cocktail (Fermentas, UK), incubated for 2 h
t 4 ◦C and clariﬁed by centrifugation at 18,000 × g at 4 ◦C for
0 min. The supernatant was diluted (1:5) using 2% fatty acid-
ree BSA in TNC buffer (50 mM Tris, pH 7.4, 150 mM  NaCl, 0.2%
HAPS) and incubated overnight at 4 ◦C with a PVDF mem-
rane. The PVDF membrane was prepared by spotting different
est chemicals (30–60 nmol) dissolved in chloroform/methanol
ixture (2:1) and blocking in 10% milk, 2% fatty acid-free
SA in TNC buffer for 2 h. After application of the lysate, the
embranes were washed and incubated with mouse anti-GFP
ntibody (1:6000; Abcam, Cambridge, UK) in 2% fatty acid-free
SA, TNC for 2 h at room temperature. An anti-mouse sec-
ndary antibody conjugated to HRP (1:10,000 dilution; Santa
ruz Biotechnology, Inc, Santa Cruz, USA) and Pierce SuperSig-
al West Femto Substrate (Thermo Fisher Scientiﬁc) were used
o detect speciﬁc binding after brief (5–10 s) exposure to an X-ray
lm.
.7. Chemicals and reagents
Steroids were purchased from Sigma or Steraloids and stock
olutions were stored according to the suppliers’ instruc-
ions. The following steroids were prepared as 5–100 mM
tocks in 100% DMSO: pregnenolone sulphate, progesterone,
7-hydroxy progesterone and 21-hydroxy progesterone, preg-
anolone, allopregnanolone, mifepristone, and nifedipine.
he following steroids were prepared as 10–50 mM stocks
n 100% ethanol: 17-oestradiol, dihydrotestosterone, aldos-
erone and cortisol. Nifedipine (50 mM)  was prepared in
00% DMSO. Thapsigargin (Sigma) was prepared as a 5 mM
tock in 100% DMSO. 2-Chloro-4-(methylsulphonyl)-N-[4-(1
yrrolidinyl)phenyl]benzenecarboxamide (2-CMNPBC, Key
rganics) was prepared as a 10 mM stock in 100% DMSO.
anthanum chloride (100 mM)  was prepared in deionised
ater.
.8. Data analysis
Origin 7.5 software (OriginLab Corporation) was  used for
ata analysis and presentation. Averaged data are expressed as
ean ± standard error of the mean (SEM). The amplitudes of
ignals were measured at the peak response. Matched groups
f control and test data were either compared using an inde-
endent t-test (intracellular Ca2+ measurement) or paired t-test
electrophysiology performed on the same cell). Each test data
et had its own control data set. Probability (P) of less than
.05 was considered statistically signiﬁcant (*); not signiﬁcant
n.s.) indicates P > 0.05. All intracellular Ca2+ measurement data
re presented as N/n, where ‘N’ is the number of wells used
n the 96-well plate and ‘n’ is the total number of independent
xperiments (i.e. on different 96-well plates). For patch-clampum 51 (2012) 1– 11 3
recordings, the number of independent recordings is indicated by
‘n’.
3. Results
3.1. Inhibition of pregnenolone sulphate responses by
progesterone
TRPM3 is a Ca2+-permeable ion channel and so we  used an
intracellular Ca2+ indicator to measure TRPM3-dependent Ca2+-
entry in HEK 293 cells. The chemical structures of pregnenolone
sulphate and progesterone are similar (Fig. 1a) but pregnenolone
sulphate stimulated TRPM3-dependent Ca2+-entry whereas pro-
gesterone did not (Fig. 1b). HEK 293 cells that were not induced
to express exogenous TRPM3 failed to respond to pregnenolone
sulphate, demonstrating the TRPM3-dependence of the response
(Fig. 1b; Supplementary Fig. I). The lack of stimulatory effect
of progesterone has been reported previously [8] but is also
evident in Fig. 1b because the baseline Ca2+ signal prior to
application of pregnenolone sulphate was  unchanged despite the
fact that progesterone had been pre-incubated with the cells
for 15 min  and maintained throughout the recordings. A novel
observation was that the presence of progesterone inhibited the
subsequent response to pregnenolone sulphate (Fig. 1b) within
2–5 min  (Fig. 1c). This effect of progesterone occurred at con-
centrations ranging from 10 nM to 10 M (Fig. 1d). The effect
was similar at room temperature (23 ± 2 ◦C) and 37 ◦C (Fig. 1d).
Progesterone caused a right-shift of the pregnenolone sulphate
concentration–response curve and reduced the slope (Fig. 1e). It
also appeared to reduce the maximum response to pregnenolone
sulphate, although this could not be fully investigated because of
steroid solubility limitations (Fig. 1e). Progesterone was not act-
ing non-speciﬁcally to suppress Ca2+ signals in the cells because
it had no effect on the activity of exogenous TRPM2 channels
(Fig. 1f) or endogenous Ca2+-release signals evoked by thapsigargin
(Fig. 1g).
Progesterone metabolites and 17-oestradiol also inhibited
TRPM3 activity but the effects were equivalent to or smaller
than those of progesterone (Fig. 2a, Supplementary Fig. II) and
were not investigated further. The progesterone-related steroid
allopregnanolone, which is a potent inhibitor of GABA-A chan-
nels [16], had no effect on TRPM3 (Fig. 2a). The corticosteroids
aldosterone and cortisol also lacked effect (Fig. 2b). Chemi-
cal structures of the steroids are shown in Supplementary Fig.
III.
Whole-cell patch-clamp was used as an independent method
to measure TRPM3 activity, enabling recordings under voltage-
clamp conditions and observation of the shape of the TRPM3
current–voltage relationship (I–V). As in the Ca2+ measurement
experiments we used a low concentration of pregnenolone sul-
phate to stimulate the channels in order to maximise the
potential physiological relevance. Therefore, the ionic current
evoked by pregnenolone sulphate was relatively small (cf. data
in Majeed et al. [8]). Over a period of 5 min  10 M proges-
terone strongly inhibited ionic current evoked by pregnenolone
sulphate (Fig. 3a). The current had the expected current–voltage
relationship (I–V) of TRPM3 (Fig. 3b) [8].  The amplitude of the
inhibitory effect was larger than that observed in Ca2+ mea-
surement assays, showing almost complete inhibition of the
channel activity (Fig. 3c cf. Fig. 1d). Progesterone (50 M)  did
not cause signiﬁcantly greater inhibition (n = 6, P > 0.05, data not
shown), suggesting that 10 M progesterone caused the max-
imum effect. Recovery from the effect of progesterone was
not detected in the 8 min  time course of the wash-out period
(Fig. 3a).
4 Y. Majeed et al. / Cell Calcium 51 (2012) 1– 11
Fig. 1. Inhibition of TRPM3-mediated Ca2+ inﬂux by progesterone. Data were generated by intracellular Ca2+ measurement. (a) Structures of pregnenolone sulphate (PregS)
and  progesterone (prog). (b) Example responses to 1 M PregS in cells induced to express TRPM3 (Tet+) in the presence of vehicle (open circles) or 10 M prog (ﬁlled black
circles). Control (Tet−) cell data (ﬁlled gray circles) are shown for comparison (no response to PregS) (N = 8 for each). (c) Cells were treated with 10 M progesterone and its
effect  on PregS-activated TRPM3 was determined after 2 min  (labelled ‘2’) and at 5 min  intervals thereafter. For every time-point, the response in the presence of progesterone
is  indicated as a percentage of the control response (N/n = 32/4). (d) Mean normalised data for the effect of different concentrations of prog (in M) at room temperature
(Room  temp., N/n = 24/3) or at 37 ◦C (N/n = 22/3). (e) Concentration–response curves for PregS in the absence (vehicle) or presence of 10 M prog (+10 prog). The ﬁtted Hill
equation gave EC50 and slope values of 1.56 M and 1.74 (vehicle) and 16.1 M and 1.06 (prog), respectively (N/n = 6/3 for each concentration of PregS). (f) Mean TRPM2
activity stimulated by 1 mM hydrogen peroxide, comparing vehicle (control) with 10 M prog (N/n = 24/3 each). (g) Mean 1 M thapsigargin (TG) responses in non-induced
(Tet−)  cells in Ca2+-free SBS, comparing vehicle (control) with 10 M prog (N/n = 24/3 each).
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The data suggest that progesterone is an inhibitor of TRPM3
hannels.
.2. Distinctions between effects of progesterone and
ihydrotestosterone
Dihydrotestosterone is chemically similar to progesterone
Fig. 4a cf. Fig. 1a). It also inhibited pregnenolone sulphate-evoked
a2+-inﬂux through TRPM3 channels (Fig. 4b). Like progesterone,
ihydrotestosterone had no effect on endogenous Ca2+ signals
voked by store-depletion with thapsigargin (Fig. 4c). How-
ver, in contrast to the effect of progesterone, the effect of
ihydrotestosterone occurred only when it was  at high concen-
ration: 50 M and not 1 M (Fig. 4d). Furthermore, the effect
f dihydrotestosterone was surmountable by high concentrations
f pregnenolone sulphate (Fig. 4e). These data suggested that
here may  be a mechanistic difference between the actions of
ihydrotestosterone and progesterone. It was hypothesised that
ihydrotestosterone competed with pregnenolone sulphate at a
inding site while progesterone inhibited TRPM3 via a separate,
regnenolone sulphate-independent, mechanism. To investigate
he hypothesis we stimulated TRPM3 using the non-steroidal agent
ifedipine [1] (Fig. 5a), the chemical structure of which is given in
upplementary Fig. III.  Progesterone inhibited nifedipine-evoked
RPM3 activity (Fig. 5b) and the amplitude of this inhibitory effect
as not signiﬁcantly different from that observed against preg-
enolone sulphate-evoked TRPM3 activity (Fig. 5c). In contrast,
ihydrotestosterone had a much smaller inhibitory effect against
ifedipine-evoked activity compared with pregnenolone sulphate-
voked activity (Fig. 5d). The data suggest that progesterone, in
ontrast to dihydrotestosterone, could inhibit TRPM3 indepen-
ently of the presence of pregnenolone sulphate.
.3. TRPM3 activity in the absence of an exogenous agonist
Although nifedipine is chemically distinct from pregnenolone
ulphate, we could not be sure that it activated TRPM3 indepen-
ently of the pregnenolone sulphate binding site. Therefore, we
lso sought TRPM3 activity in the absence of an exogenous agonist.
ver-expressed human TRPM3 has been shown to have consti-
utive activity [9].  However, in our tetracycline-inducible TRPM3
ells (in the presence of 1.5 mM extracellular Ca2+) such activity
as not evident as a basal Ca2+ signal (Fig. 1b; Supplementary Fig.
V) or ionic current (Supplementary Fig. IV).  Therefore we used
 Ca2+ add-back protocol in which 5 mM Ca2+ was  added to cellsd by whole-cell patch-clamp. (a) Example time-series showing the effect of 10 M
as constant throughout). (b) For the experiment of (a), PregS-evoked I–V in vehicle
ed to pre-prog amplitudes (n = 8).
after a period in Ca2+-free solution (Fig. 6). This protocol revealed
a Ca2+ response in TRPM3-expressing as well as control cells but
the response was signiﬁcantly larger in the presence of TRPM3
(Supplementary Fig. V). Therefore we  used this signal to investi-
gate effects of progesterone and dihydrotestosterone in the absence
of an exogenous TRPM3 agonist. Progesterone inhibited the sig-
nal in TRPM3-expressing but not control cells (Fig. 6a, c), whereas
dihydrotestosterone had no effect in either set of cells (Fig. 6b,
d). The data support the hypothesis that progesterone inhibited
TRPM3 independently of competition with an exogenous agonist,
apparently acting as a mode-independent inhibitor. Dihydrotestos-
terone, by contrast, had an inhibitory effect that depended on the
presence of the agonist pregnenolone sulphate.
3.4. Progesterone receptor
A mechanism by which progesterone might act on TRPM3 is via a
classical progesterone receptor. To investigate this possibility, cells
were pre-incubated with the progesterone receptor antagonist
mifepristone [17]. At 1–2 M mifepristone strongly antagonises
the progesterone receptor. Mifepristone (2 M)  had an effect of its
own on TRPM3-mediated Ca2+ inﬂux (24% inhibition) but sufﬁcient
TRPM3 activity remained to test progesterone (Fig. 7a, b). The inhi-
bition caused by progesterone in the presence of mifepristone was
slightly more than in the absence of mifepristone (52% cf. 44% inhi-
bition) (Fig. 7a, b). Mifepristone (1 M)  had no effect of its own on
TRPM3 and also did not inhibit the effect of progesterone (data not
shown). The data suggest that progesterone did not act on TRPM3
through classical progesterone receptors.
3.5. Binding to TRPM3 or a closely associated partner
To investigate whether progesterone or other substances might
bind to TRPM3 we performed overlay assays in which cell lysates
were applied to membranes spotted with progesterone, preg-
nenolone sulphate, dihydrotestosterone, cortisol, nifedipine or
cholesterol (Fig. 8). Cells were transiently transfected with human
TRPM3 tagged with YFP, or GFP-only as a control. Proteins adhering
to the spots were detected with anti-GFP antibody, which also binds
YFP, a mutant of GFP. TRPM3 bound to pregnenolone sulphate, pro-
gesterone, nifedipine, dihydrotestosterone and cholesterol, where
as there was no binding to cortisol (Fig. 8). The data are con-
sistent with functional assays in which pregnenolone sulphate,
progesterone, nifedipine, dihydrotestosterone and cholesterol have
effects on TRPM3 activity but cortisol does not. The data suggest
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he steroid backbone; an inhibitor was identiﬁed [8].  Here we show
nother of these compounds, 2-chloro-4-(methylsulphonyl)-N-[4-
1 pyrrolidinyl)phenyl]benzenecarboxamide (2-CMNPBC, Fig. 9a),
hich also inhibited pregnenolone sulphate-evoked TRPM3 activ-
ty (Fig. 9b, c). Strikingly, the compound had no effect against
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nifedipine-evoked TRPM3 activity (Fig. 9d, e). Therefore, the look-
alike compound mimicked the effect of dihydrotestosterone as an
inhibitor of only pregnenolone sulphate-evoked TRPM3 activity.
3.7. Endogenous channels
The above data were generated from HEK 293 cells that
conditionally over-expressed human TRPM3. To investigate the rel-
evance to endogenous TRPM3 we  measured Ca2+-inﬂux evoked
by pregnenolone sulphate in human vascular smooth muscle
cells (VSMCs), which is mediated at least partly by TRPM3 [3].
Pregnenolone sulphate (25 M)  was  used in these experiments
because the pregnenolone sulphate concentration–response curve
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Fig. 8. Chemical interaction with TRPM3. Typical result for lysate from HEK 293 cells expressing GFP alone (control) or TRPM3-YFP (TRPM3) incubated with membranes
that  had been spotted with the indicated chemicals at 30 or 60 nmol (left panel). Detection occurred using anti-GFP antibody. The results for dihydrotestosterone (DhT) and
cortisol are duplicated with enhanced contrast in the right panel. The data are representative of three independent experiments.
Fig. 9. Competition with a non-steroidal look-alike chemical. (a) 3-Dimensional overlay of PregS with the look-alike chemical, 2-CMNPBC. (b), (d) In Tet+ cells, example
responses to 1 M PregS (b) or 20 M nifedipine (nif) (d) in the presence of vehicle or 10 M 2-CMNPBC (N = 4 for each). (c), (e) Mean data for experiments exempliﬁed in
(b)  and (d) (N/n = 12/3).
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s right-shifted compared with that of over-expressed TRPM3 [3].
rogesterone 10–100 M inhibited this pregnenolone sulphate-
voked Ca2+ signal (Fig. 10). The data suggest that endogenous
RPM3 channels can be inhibited by progesterone.
We speculated that progesterone regulation of TRPM3 might
lso be relevant to the female reproductive system where proges-
erone has potent biological effects. A previous report suggested
RPM3 expression in human ovaries [9].  There were no reports of
unctional TRPM3 channels in this context and so we  investigated
f functional channels exist by making whole-cell patch-clamp
ecordings from granulosa cells freshly isolated from bovine
varian follicles [14]. In K+-current recording solutions, A-type K+-
urrent was observed (Supplementary Fig. VI),  as expected for this
ell type [18]. In TRPM3 recording solutions, pregnenolone sulphate
voked large ionic currents but only after delays of several minutes
Fig. 11a, d), which is not expected for TRPM3 (cf. Fig. 3a). The I–Vs
f the evoked currents were almost linear (Fig. 11b, e), which is
ot standard for TRPM3 (cf. Fig. 3b), although has been observed
n some recordings [19]. Progesterone did not inhibit the currents
voked by pregnenolone sulphate (Fig. 11a–f). The data suggest that
ranulosa cells contain ionic currents that are stimulated by preg-
enolone sulphate but that these currents may  not be mediated by
RPM3 and are not inhibited by progesterone.
. Discussion
The study has revealed relatively rapid effects of sex steroids
n TRPM3. All effects were inhibitory but there were two  dis-
inct mechanisms: one was observed with dihydrotestosterone,
he other with progesterone. In the case of dihydrotestosterone,
he effect occurred only at high (non-physiological) concentrations
nd appeared to be due to the steroid competing at a binding
ite with pregnenolone sulphate. Similar effects were observed
ith a non-steroid look-alike compound. Progesterone, by contrast,
as more potent, showing effects at 10 nM and having maximum
ffect at 10 M.  Furthermore, a characteristic of progesterone’s
ffect was that it was retained in the absence of pregnenolone
ulphate or other exogenous TRPM3 activators, suggesting a gen-
ral inhibitory effect on all modes of TRPM3 activity. Overlay
ssays suggested binding of pregnenolone sulphate, progesterone
nd dihydrotestosterone to TRPM3. The data support the concept
f a binding site for pregnenolone sulphate on TRPM3 at whichum 51 (2012) 1– 11 9
competition occurs (e.g. with dihydrotestosterone or steroid look-
alike compounds) but also suggest the existence of a mechanism by
which progesterone binds and inhibits TRPM3. Progesterone may
bind at or near the pregnenolone sulphate site but its inhibitory
effect did not depend on the presence of pregnenolone sulphate.
The ﬁndings compare favourably to recent evidence of TRPC5
sensitivity to steroids in which progesterone and dihydrotestos-
terone were inhibitory [20]. Similar to TRPM3, -oestradiol and
cortisol had less or no effect [20]. Relatively rapid effects of pro-
gesterone have also been observed on other types of ion channel,
although mostly at relatively high, micromolar, concentrations.
Inhibition of voltage-dependent and Ca2+-activated K+ currents
was observed in T cells but there was no effect on Ca2+-release-
activated Ca2+ (CRAC) channel current [21]. P2X channel activity
was potentiated by progesterone [22], as was activity of glycine
and GABA-A receptors [23]. In the heart, nanomolar progesterone
enhanced K+-current (IKs) under basal conditions and inhibited Ca2+
current (ICa,L) under cyclic AMP-stimulated conditions; the effects
occurred through a PI3-kinase signalling pathway in caveolae
[24]. Progesterone stimulated the sperm-speciﬁc Ca2+-permeable
CatSper channel with an EC50 in the range of 8–66 nM [25,26]. It
has been suggested that special G protein-coupled receptors might
mediate non-genomic effects of progesterone [27] but G protein-
coupled receptor modulation of TRPM3 channels has not, so far,
been identiﬁed [3].
Effects of progesterone on TRPM3 were observed at the high
end of the physiologically relevant concentration range, which
has been observed to be 1–2 nM rising to 30–50 nM in the luteal
phase of the menstrual cycle [28,29]. This raises the possibility that
TRPM3 is regulated by progesterone in vivo. Our  observations did
not support a role for TRPM3 or its regulation by progesterone in
the ovaries, but this is only one aspect of the reproductive sys-
tem and there may  be important differences in relation to TRPM3
in humans, cows and various hormonal contexts. Therefore, fur-
ther investigation of TRPM3 and its steroid sensitivity is still likely
to be worthwhile. It was  notable that the endogenous TRPM3
signal in vascular smooth muscle cells was  less sensitive to pro-
gesterone compared with TRPM3 over-expressed in HEK 293 cells.
An explanation for this difference could be that the progesterone
mechanism is regulated, perhaps by other types of TRP protein
that contribute to the TRPM3-related signal, affecting progesterone
sensitivity. It should be considered whether heat is relevant to
the steroid sensitivity of TRPM3 because Ca2+ events occurred in
response to concentrations of pregnenolone sulphate as low as
0.1 M in 37 ◦C recordings from HEK 293 cells expressing mouse
TRPM3 [4].  Therefore, in the contexts of normal body temperature,
fevers or hot ﬂushes, steroids may  have greater ability to modu-
late TRPM3 channels; if there is noxious heat, there may be even
stronger effects. Against this hypothesis is our observation that
the effect of progesterone was not different at 37 ◦C (Fig. 1d). Fur-
thermore, we  did not observe enhanced potency of pregnenolone
sulphate when recording Ca2+ entry through human TRPM3 in HEK
293 cells at 37 ◦C (Supplementary Fig. VII). Our studies have focused
on human TRPM3, however. There are substantial species differ-
ences in TRPM3 sequence between mouse and human and quite
large numbers of splice variants [30]. These differences in sequence
may  be important in the effects of temperature.
In conclusion, the study provides further insight into the chem-
ical structures that interact with the steroid agonistic binding site
associated with TRPM3 channels, supporting the concept of a bind-
ing site on or very near to TRPM3 and providing information about
interaction with the male sex steroid dihydrotestosterone and
non-steroid antagonists. In addition, the study reveals a separate
non-genomic steroid effect on TRPM3 that is inhibitory and poten-
tially relevant to physiological progesterone (or other steroids not
yet investigated in relation to this mechanism). The inhibitory
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ffect does not depend on the presence of the TRPM3 agonist preg-
enolone sulphate although it would be premature to exclude any
nteraction between the progesterone and pregnenolone sulphate
echanisms. This previously unrecognised steroid effect of proges-
erone is relatively rapid in its onset but slower than the agonist
ffect of pregnenolone sulphate.
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